18
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Use of Left-Ventricular Assist with the Hemopump TM in Cardiac Surgery

      research-article

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          From July 1989 to May 1992 16 patients received circulatory support with a Hemopump<sup>TM</sup> assist device in the Department of Cardiac Surgery of the Katholieke Universiteit Leuven. The mean age of those patients was 56+13 years (ranging from 23 to 72 years). The mean time of assisted circulation was 60 ± 46 h (ranging from 2 to 168 h). Group I consists of 13 patients who received the device after postcardiotomy cardiac failure (survival 38%). Group II includes 1 patient who received the pump prior to repair of a large postinfarction ventricular septal defect (survival 0%). Group III consists of 2 patients for whom the Hemopump was used as a bridge to cardiac retransplantation. Both are still alive (survival 100%). If the 21-F Hemopump is implanted following a critical indication it can be used rather successfully for mechanical circulatory support.

          Related collections

          Author and article information

          Journal
          CRD
          Cardiology
          10.1159/issn.0008-6312
          Cardiology
          S. Karger AG
          978-3-8055-5957-7
          978-3-318-01955-1
          0008-6312
          1421-9751
          1994
          1994
          18 November 2008
          : 84
          : 3
          : 211-215
          Affiliations
          Departments of Cardiac Surgery and Anesthesiology, Katholieke Universiteit Leuven, Belgium
          Article
          176400 Cardiology 1994;84:211–215
          10.1159/000176400
          8205571
          6a35d9ad-2fdd-4e50-9885-ba81f87245f3
          © 1994 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          History
          Page count
          Pages: 5
          Categories
          Paper

          General medicine,Neurology,Cardiovascular Medicine,Internal medicine,Nephrology
          Axial flow pump,Mechanical circulatory support,Interventional cardiology,Cardiac surgery,Postcardiotomy cardiac failure,HemopumpTM

          Comments

          Comment on this article